Response to “Letter to Editor-in-Chief” and “Redefining Resectability: Bridging Perspectives in Stage III NSCLC Management”

Ilias Houda; Idris Bahce; Jordi Remon; Thierry Berghmans; Corinne Faivre-Finn; Anne Marie C. Dingemans; Benjamin Besse; Lizza E.L. Hendriks

doi:10.1016/j.lungcan.2025.108510

Response to “Letter to Editor-in-Chief” and “Redefining Resectability: Bridging Perspectives in Stage III NSCLC Management”

Ilias Houda, Idris Bahce, Jordi Remon, Thierry Berghmans, Corinne Faivre-Finn, Anne Marie C. Dingemans, Benjamin Besse, Lizza E.L. Hendriks

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

langue originale	Anglais
Numéro d'article	108510
journal	Lung Cancer
Volume	203
Les DOIs	https://doi.org/10.1016/j.lungcan.2025.108510
état	Publié - 1 mai 2025

Accès au document

10.1016/j.lungcan.2025.108510

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{7a75d71ef11a490d932a3027cd97bb72,

title = "Response to “Letter to Editor-in-Chief” and “Redefining Resectability: Bridging Perspectives in Stage III NSCLC Management”",

author = "Ilias Houda and Idris Bahce and Jordi Remon and Thierry Berghmans and Corinne Faivre-Finn and Dingemans, {Anne Marie C.} and Benjamin Besse and Hendriks, {Lizza E.L.}",

year = "2025",

month = may,

day = "1",

doi = "10.1016/j.lungcan.2025.108510",

language = "English",

volume = "203",

journal = "Lung Cancer",

issn = "0169-5002",

}

TY - JOUR

T1 - Response to “Letter to Editor-in-Chief” and “Redefining Resectability

T2 - Bridging Perspectives in Stage III NSCLC Management”

AU - Houda, Ilias

AU - Bahce, Idris

AU - Remon, Jordi

AU - Berghmans, Thierry

AU - Faivre-Finn, Corinne

AU - Dingemans, Anne Marie C.

AU - Besse, Benjamin

AU - Hendriks, Lizza E.L.

PY - 2025/5/1

Y1 - 2025/5/1

UR - http://www.scopus.com/inward/record.url?scp=105001264342&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2025.108510

DO - 10.1016/j.lungcan.2025.108510

M3 - Letter

AN - SCOPUS:105001264342

SN - 0169-5002

VL - 203

JO - Lung Cancer

JF - Lung Cancer

M1 - 108510

ER -